Complete Masterclass: Regenerative Medicine + Peptide Therapeutics

This comprehensive course provides healthcare professionals with foundational and advanced instruction in regenerative medicine and peptide therapeutics. Participants will examine the biological mechanisms of tissue repair, major regenerative platforms, peptide biology and pharmacology, manufacturing and quality considerations, patient selection, treatment delivery, peri-procedural care, rehabilitation, safety, regulatory requirements, and outcome measurement.

The course progresses from core principles to the clinical application of regenerative approaches across a range of complex conditions, including orthopedic and neurologic disorders, autism, addiction, autoimmune disease, Parkinson’s disease, liver and lung disorders, fertility concerns, hair restoration, neurovascular disease, cognitive decline and Alzheimer’s disease, longevity medicine, and nonischemic cardiomyopathy. Through evidence review and physician-focused case discussions, participants will evaluate patient phenotypes, treatment sequencing, monitoring strategies, multidisciplinary coordination, and the limitations of current research.

Emphasis is placed on evidence-based clinical reasoning, responsible integration with established standards of care, informed consent, ethical patient communication, longitudinal outcome assessment, and the safe and appropriate use of emerging regenerative biologics, peptides, oxygen-based interventions, and supportive rehabilitation strategies.

Target Audience

This activity is designed for an audience of physicians and other qualified healthcare professionals involved in regenerative medicine, peptide therapeutics, neurology, psychiatry, addiction medicine, internal medicine, cardiology, pulmonology, hepatology, rheumatology, fertility medicine, dermatology, pain medicine, physical medicine and rehabilitation, and longevity medicine. The course is also appropriate for nurse practitioners, physician assistants, and other licensed clinicians seeking advanced, evidence-informed education in the evaluation and management of complex cases.

Learning Objectives

Upon completion of this activity, participants should be able to:

Explain the biological mechanisms underlying tissue repair, regenerative medicine, and peptide-based therapies.
Evaluate the available clinical evidence, potential benefits, limitations, and safety considerations associated with regenerative biologics, peptides, and other emerging therapeutic approaches.
Identify appropriate patient-selection criteria and develop individualized treatment strategies based on disease presentation, clinical phenotype, comorbidities, and established standards of care.
Apply evidence-based principles to the use of regenerative and peptide therapies across orthopedic, neurologic, autoimmune, cardiometabolic, pulmonary, hepatic, reproductive, cognitive, and longevity-related conditions.
Develop appropriate treatment sequencing, delivery, monitoring, rehabilitation, and longitudinal outcome-assessment plans for patients receiving regenerative interventions.
Integrate regulatory requirements, manufacturing and quality considerations, informed consent, ethical communication, and risk-management principles into regenerative medicine practice.
Collaborate with multidisciplinary healthcare teams to safely incorporate regenerative therapies alongside conventional medical treatments and supportive care.

Commercial Support
There is no commercial support for this activity.

Course summary

Available credit:

14.00 AANP Contact Hours
Nurse Practitioners
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Institute for Regenerative Medicine and Neuroscience. AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 14.00 contact hour(s) (which includes 14.00 hour(s) of pharmacology).
- 14.00 AANP Pharmacology Contact Hours
14.00 AAPA Category 1 CME
Physician Associates
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 14.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
14.00 AMA PRA Category 1 Credit™
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this Enduring Material for a maximum of 14.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
14.00 ANCC Contact Hours
Nurses
Credit being awarded: 14.00 ANCC contact hours
14.00 AMA PRA Category 1 Credit™ Non-MD
Non-Physicians Seeking AMA Credit
AKH Inc., Advancing Knowledge in Healthcare designates this Enduring Material for a maximum of 14.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course opens:

08/24/2026

Course expires:

12/31/2027

Cost:

$0.00

Rating:

All of the relevant financial relationships listed for these individuals have been mitigated.

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.

Committee Member, Planner, Staff(s)